| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Helix Acquisition Corp. II | Former Director | Common Stock | 30,000 | $321,519 | $10.72 | 11 Aug 2025 | Direct |
| Helix Acquisition Corp. II | Former Director | Class B ordinary shares | 0 | 11 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HLXB | BridgeBio Oncology Therapeutics, Inc. | 11 Aug 2025 | 2 | $0 | 4 | Former Director | 11 Aug 2025, 17:04 |
| HLXB | Helix Acquisition Corp. II | 08 Feb 2025 | 0 | $0 | 3 | Director | 11 Feb 2025, 17:16 |